Find a Psoriasis Clinical Trial Near You | Clinical Trials GPS
Currently enrolling clinical research studies | Olympian Clinical Research | Tampa, FL & Clearwater, FL
Management of Plaque Psoriasis: A Review and Comparison of IL-23 Inhibitors - European Medical Journal
Potential Psoriasis Treatment - Clinical Research Trials
Bimekizumab versus Adalimumab in Plaque Psoriasis | NEJM
Analyzing Psoriasis Clinical Trial Samples | Figure 1
Studies | Plaque Psoriasis – Indiana Clinical
Plaque Psoriasis (Psoriasis Vulgaris) - Global Clinical Trials Review, 2022
Patient enrollment completed for Dermavant phase 3 psoriasis clinical trials
Apremilast mechanism of efficacy in systemic-naive patients with moderate plaque psoriasis: Pharmacodynamic results from the UNVEIL study - Journal of Dermatological Science
Data from the Otezla ESTEEM Clinical Trial | Otezla® (apremilast) Healthcare Professional Site
Psoriasis - San Diego CA (Clinical Trial # 34134)
Paid Clinical Trials in Colorado | Physicians Research Group | Moving Forward. Together.
psoriasis-ad - Colorado Center for Dermatology & Skin Surgery
Short-term effectiveness of biologics in patients with moderate-to-severe plaque psoriasis: A systematic review and network meta-analysis - Journal of Dermatological Science
Long-term Efficacy and Safety of Tildrakizumab: 5-year Results from the reSURFACE 1 and 2 Phase III Trials in Patients with Moderate-to-severe Plaque Psoriasis - European Medical Journal
Guselkumab versus secukinumab for the treatment of moderate-to-severe psoriasis (ECLIPSE): results from a phase 3, randomised controlled trial - The Lancet
Pediatric Plaque Psoriasis - Santa Ana CA (Clinical Trial # 39805)
A phase 2b, randomized clinical trial of tapinarof cream for the treatment of plaque psoriasis: Secondary efficacy and patient-reported outcomes - Journal of the American Academy of Dermatology
Plaque Psoriasis (Psoriasis Vulgaris) - Global Clinical Trials Review, H2, 2021
Metro Boston Clinical Partners | Studies | Psoriasis
New psoriasis drug effective for three-quarters of patients in clinical trial - UPI.com
FDA approves Roivant drug, the first novel topical plaque psoriasis med in 25 years - MedCity News
Psychiatric adverse events during treatment with brodalumab: Analysis of psoriasis clinical trials - Journal of the American Academy of Dermatology
Plaque Psoriasis (Psoriasis Vulgaris) - Global Clinical Trials Review, 2022
